Recent Review on Biological Barriers and Host–Material Interfaces in Precision Drug Delivery: Advancement in Biomaterial Engineering for Better Treatment TherapiesReview Published on 2024-08-162024-09-05 Journal: Pharmaceutics [Category] update2024, [키워드] Biological barriers biomaterial drug delivery drug molecule Nanotechnology precision therapy [DOI] 10.3390/pharmaceutics16081076 PMC 바로가기 [Article Type] Review
The Chicken Egg: An Advanced Material for Tissue EngineeringReview Published on 2024-04-042024-09-05 Journal: Biomolecules [Category] update2024, [키워드] biomaterial Egg Egg white egg yolk Eggshell eggshell membrane hydrogel tissue engineering [DOI] 10.3390/biom14040439 PMC 바로가기 [Article Type] Review
Clinical and Biochemical Implications of Hyaluronic Acid in Musculoskeletal Rehabilitation: A Comprehensive ReviewReview Published on 2023-11-262024-09-05 Journal: Journal of Personalized Medicine [Category] update2024, [키워드] active biomolecule biomaterial HA injection Hyaluronic acid Physical therapy rehabilitation [DOI] 10.3390/jpm13121647 PMC 바로가기 [Article Type] Review
Harnessing cell reprogramming for cardiac biological pacingarticle Published on 2023-08-262024-09-05 Journal: Journal of Biomedical Science [Category] update2024, [키워드] Biological pacemaker biomaterial bradyarrhythmia Electronic pacemaker Functional re-engineering gene transfer reprogramming silk fibroin sinoatrial node stem cell [DOI] 10.1186/s12929-023-00970-y PMC 바로가기 [Article Type] article
A Hybrid Biological-Biomaterial Vector for Antigen Deliveryarticle Published on 2021-12-312024-09-01 Journal: Methods in molecular biology (Clifton, N.J.) [Category] 폐렴구균 감염증, [키워드] biomaterial DNA vaccine Escherichia coli immunogenicity vaccine delivery [Article Type] article
A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens모듈식 생체 재료 스캐폴드 기반 백신은 소단위 SARS-CoV-2 항원에 대한 내구성 있는 적응 면역을 유도합니다Article Published on 2021-11-012022-09-11 Journal: Advanced Healthcare Materials [Category] MERS, SARS, 변종, 진단, [키워드] activate adaptive Adaptive immunity antibodies antibody Antigen antigen-presenting cell antigen-presenting cells APCS biomaterial cellular colony-stimulating factor coronavirus disease Coronavirus disease 2019 Course COVID-19 COVID-19 vaccine cytotoxic cytotoxic T-cells described facilitate generate GM-CSF granulocyte granulocyte-macrophage colony-stimulating factor Humoral response immune responses Immunity in vitro injection lack mesoporous silica rods Monophosphoryl lipid A monophosphoryl lipid A (MPLA) MPLA pandemic Pathogens persistent platform poorly immunogenic Protein protein antigen RBD Receptor binding domain recombinant proteins recruit regimen robust rod Safe SARS-CoV-2 SARS-CoV-2 antigens SARS-CoV-2 variant SARS-CoV-2 viral silica Subunit vaccine subunit vaccines T-cells tested Toll-like receptor toll-like receptor 4 Vaccine vaccine platform Vaccines Viral viral neutralization [DOI] 10.1002/adhm.202101370 PMC 바로가기 [Article Type] Article
Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID‐19 Vaccines생체 재료 및 산소 결합 힘을 결합하여 면역 반응을 형성하고 Covid -19 백신을 향상시킵니다.Research Article Published on 2021-07-202022-08-31 Journal: Advanced Science [Category] SARS, 치료제, [키워드] activate acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 adaptive immune system antibody Antibody titer Antibody titers antigens approach Arm binding biomaterial boost coronavirus coronavirus disease Coronavirus disease 2019 COVID‐19 COVID‐19 CpG Critical demonstrated Diseases dose effective effective vaccine Effective vaccines Effectiveness Emerging infectious diseases Engineering force generate GM‐CSF Health Health crisis immune response immune stimulation immunization immunized immunogenicity immunological immunomodulatory immunostimulation Infectious diseases injectable cryogel lack mice Neutralizing antibodies neutralizing antibody nucleocapsid offer overcome oxygen platform preclinical studies protective antibodies Protein Protein subunit vaccines RBD receptor‐binding domain reported required respiratory response resulting robust SARS‐CoV‐2 SARS‐CoV‐2 protein second dose severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccine shape Subunit vaccine subunit vaccines sustained Th1 Th2 Vaccine virus [DOI] 10.1002/advs.202100316 PMC 바로가기 [Article Type] Research Article
Periodic thermomechanical modulation of toll-like receptor expression and distribution in mesenchymal stromal cellsResearch Letter Published on 2021-07-082022-10-30 Journal: Mrs Communications [Category] COVID-19, [키워드] Abstract Actuation Antiviral biomaterial combating COVID-19 Culture distribution driven by expressing expression F-actin highlight immune response Immunity modulation MSC MSCs Periodic Polymer promoted proportion provided receptor recruited retained SARS-CoV-2 Shape memory stromal cell synchronous TLR TLR4 TLR7 TLRs Toll-like receptor virus was increased [DOI] 10.1557/s43579-021-00049-5 PMC 바로가기 [Article Type] Research Letter
Biomaterials-based formulations and surfaces to combat viral infectious diseasesReviews Published on 2021-03-092022-10-28 Journal: APL Bioengineering [Category] COVID-19, [키워드] acute respiratory syndrome Antiviral antiviral properties approach biomaterial clinical trial contagious coronavirus drug Ebola effective herbal medicine hydrophobic immunomodulatory inhibit introduced Modification molecular novel antiviral drug offer platform Polymer Prevent public health recognize reduce Research risk Safe SARS-CoV-2 translation Vaccine viral infection viral infections viral infectious disease Viral load virus virus replication viruses Zika [DOI] 10.1063/5.0029486 PMC 바로가기 [Article Type] Reviews
Coronavirus disease 2019: A tissue engineering and regenerative medicine perspectiveConcise Review Published on 2020-08-212022-10-28 Journal: Stem cells translational medicine [Category] COVID-19, MERS, [키워드] acute respiratory distress acute respiratory distress syndrome antiviral agent Antiviral agents ARDS biomaterial caused cell processing clinical trial clinical trials conducted Coronavirus infections COVID‐19 current death derivative described disease Disease progression driving Effect effective Efficacy evaluate Exosomes Impact infective Inflammation Last majority medical need mesenchymal stem cell MSC MSC therapy MSCs novel coronavirus disease pandemic Perspective platform progression regenerative required Research Safe stem cell syndrome the disease Therapeutic benefit Therapies therapy tissue Treatment Vaccine [DOI] 10.1002/sctm.20-0197 PMC 바로가기 [Article Type] Concise Review